Zobrazeno 1 - 10
of 13
pro vyhledávání: '"利妥昔单抗"'
Autor:
LI Aijuan (李爱娟)
Publikováno v:
中西医结合护理, Vol 7, Iss 5, Pp 75-77 (2021)
This paper reviewed the clinical data of 5 patients with cryoglobulinemia-associated membranoproliferative glomerulonephritis(MPGN), and summarized the Rituximab treatment (RTX) paln, medication care and nursing process. A single dose of rituximab wa
Externí odkaz:
https://doaj.org/article/c6e37d9670214f46a1864f55dd6e9efd
Publikováno v:
Chinese Journal of Hematology
目的 探讨FCR方案（氟达拉滨+环磷酰胺+利妥昔单抗）一线治疗慢性淋巴细胞白血病（CLL）的疗效。 方法 回顾性分析2004年5月至2017年12月一线应用FCR方案治疗的43例CLL患者的临床资料。 结果
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::469e72fae8f090c889c8710dc943c14d
http://europepmc.org/articles/PMC8408492
http://europepmc.org/articles/PMC8408492
Autor:
Y, Li, X Y, Gong, X L, Zhao, H, Wei, Y, Wang, D, Lin, C L, Zhou, B C, Liu, H J, Wang, C W, Li, Q H, Li, B F, Gong, Y T, Liu, S N, Wei, G J, Zhang, Y C, Mi, J X, Wang, K Q, Liu
Publikováno v:
Chinese Journal of Hematology
目的 探讨利妥昔单抗联合短疗程、高强度方案治疗成人Burkitt白血病患者的疗效和安全性。 方法 收集2006年1月30日至2018年9月12日中国医学科学院血液病医院收治的11例Burkitt白血病患者病例资
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d3416047e4c18d0e3d7cd88aaf161d9e
https://pubmed.ncbi.nlm.nih.gov/32654465
https://pubmed.ncbi.nlm.nih.gov/32654465
Publikováno v:
Chinese Journal of Hematology
目的 探究滤泡性淋巴瘤（FL）的临床特征，以及FL国际预后指数（FLIPI）、FLIPI2、IPI、修正IPI（R-IPI）、NCCN-IPI在中国FL患者的预后意义。 方法 对2008年11月至2018年4月期间以利妥昔单抗联合CHOP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d5eab04dd33ccef693665f35c19d5ddd
https://pubmed.ncbi.nlm.nih.gov/30704228
https://pubmed.ncbi.nlm.nih.gov/30704228
Publikováno v:
Chinese Journal of Hematology
目的 探讨17例原发性冷凝集素病（CAD）患者的临床特征、治疗及转归。 方法 回顾性分析2007年4月至2016年10月北京协和医院确诊的17例原发性CAD患者的临床资料、治疗和转归，并检测了其中4例
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f5a46c079bb82ea30f8b8243bd11a7a8
http://europepmc.org/articles/PMC7348369
http://europepmc.org/articles/PMC7348369
Publikováno v:
Chinese Journal of Hematology
目的 探讨重型地中海贫血（地贫）患者异基因造血干细胞移植（allo-HSCT）后并发自身免疫性溶血性贫血（AIHA）诊断、治疗及转归，以提高地贫患者造血干细胞移植疗效。 方法 回顾性分析200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::32a9d1a730ee1058a28a040af3415c4d
https://pubmed.ncbi.nlm.nih.gov/30486586
https://pubmed.ncbi.nlm.nih.gov/30486586
Publikováno v:
Chinese Journal of Hematology
To evaluate the outcome of surgical resection and rituximab for treatment of primary gastric diffuse large B cell lymphoma (PGDLBCL).Data of 83 patients with primary gastric diffuse large B cell lymphoma were reviewed retrospectively. 40 patients rec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f3046ae4412dbb2d5cb682e2a0d8b7d8
http://europepmc.org/articles/PMC7364997
http://europepmc.org/articles/PMC7364997
Publikováno v:
Chinese Journal of Hematology
To analyze the prevalence of Epstein Barr Virus (EBV) infection in patients following allogeneic hematopoietic stem cell transplantation (allo-HSCT).The occurrence of EBV viremia, EBV disease and post-transplant lymphoproliferative disease (PTLD) wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::22992aaf4d63392a6f162ef569b1a07c
http://europepmc.org/articles/PMC7348195
http://europepmc.org/articles/PMC7348195
Publikováno v:
Chinese Journal of Hematology
To observe the efficacy of high-dose dexamethasone in combination with low-dose rituximab as a second-line treatment for patients with immune thrombocytopenia (ITP).65 patients with ITP, previously by conventional dose of glucocorticoids, received hi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::6962ad1be782214542b18f5f23a9b110
http://europepmc.org/articles/PMC7342512
http://europepmc.org/articles/PMC7342512
Publikováno v:
Chinese Journal of Hematology
To study the efficacy and safety of rituximab (RTX) in the treatment of idiopathic thrombotic thrombocytopenic purpura (ITTP).Among 17 ITTP patients, nine cases of the RTX group were administrated with RTX plus plasma exchange (PEX) and steroids. Eig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::02ddd3473ac5e6efe09b007f214c8ae0
http://europepmc.org/articles/PMC7342611
http://europepmc.org/articles/PMC7342611